Nobuki Ishida

Nobuki Ishida

Auto-generated profile, based on publicly available information

Nobuki Ishida

Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2019 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
NINobuki Ishida
Nobuki Ishida
KIKohei Ishiyama
Kohei Ishiyama
YSYoshihiro Saeki
Yoshihiro Saeki
YTYuka Tanaka
Yuka Tanaka
HOHideki Ohdan
Hideki Ohdan
The activation of natural killer (NK) cells in the liver inhibits engraftment of intraportally transplanted islets. We attempted to modulate the activity of NK cells by co‐transplanting mesenchymal stem cells (MSCs) with islets in mice. We first investigated the ability of MSCs to secrete prostaglandin E2 (PGE2), a predominant inhibitor of NK cell function, in various combinations of inflammatory cytokines. Notably, we found that PGE2 production was partially delayed in MSCs activated by inflammatory cytokines in vitro, whereas liver NK cells were activated early after islet transplantation in vivo. Accordingly, pre‐activated MSCs, but not naive MSCs, substantially suppressed the expression of activation markers in liver NK cells after co‐transplantation with islets. Similarly, co‐transplantation with pre‐activated MSCs, but not naive MSCs, markedly improved the survival of islet grafts. These results highlight MSC co‐transplantation as an effective and clinically feasible method for enhancing engraftment efficiency.